|
From our partners at Stansberry Research
Dear Reader, The stock market just entered a highly dangerous new phase – which is going to have dramatic consequences for your money this summer. The signs are everywhere: SpaceX just went public. OpenAI and Anthropic will likely follow it. If you're thinking of buying into any of these IPOs... PLEASE DON'T. They're likely to be disasters – the most overhyped, overvalued large-cap stocks of all time, foisted on gullible investors by Wall Street insiders. At the same time, the President and his family are openly picking winners in the stock market... while a 24-year-old just founded his own hedge fund and made $5 billion in less than a year. But it's what's coming NEXT that I'm most worried about. I've spent 30 years on Wall Street. I have my MBA from Harvard and spend my time in correspondence with billionaires like Warren Buffett and Bill Ackman. I've forecast the collapse of dozens of stocks. But what I see happening today scares me – as a former money manager, as a father, and as an American. Because our country is headed toward an economic event unlike anything we've seen in over 100 years. Perhaps you see the signs too. Or maybe you just feel it – that creeping, nagging doubt that tells you something is dangerously wrong in our country. If that's you, I'd urge you... listen to your gut. If you care about your wealth, your family, and your future, you need to understand what's really coming. I've put together a free analysis explaining exactly what I see, and the specific steps I recommend you take with your money today. I strongly encourage you to check it out here. Regards, Whitney Tilson
Editor, Stansberry Investment Advisory
Former Hedge Fund Manager
Co-Founder, Teach for America
Harvard MBA P.S. What's happening today will reset the financial system in a way most of us can't imagine. If I'm even half-right, it's going to have a huge impact on your money and your future. Get the details here...
Additional Reading from MarketBeat Media
Can Trupanion Turn Pet Insurance Loyalty Into Real Earnings?Submitted by Peter Frank. Article Published: 6/18/2026. 
Key Points
- Trupanion beat Q1 expectations and posted record first-quarter subscription margins, but the stock has continued to struggle.
- Subscriber retention remains a strength, helping support the company’s monthly pet insurance model despite competitive pressure.
- The bull case depends on Trupanion proving that revenue growth and customer loyalty can translate into durable profitability.
- Special Report: Three oil giants buried the same discovery for 50 years
Trupanion (NASDAQ: TRUP) has spent years telling investors a compelling story about pet insurance. Yet despite steadily rising revenue over the years, the company has struggled to translate that growth into profits. Now, after a strong first quarter that builds on positive results from 2025, Trupanion is delivering record margins, an earnings beat, and solid subscriber retention.
Analyst Ross Givens says the top AI opportunity right now isn't Microsoft, Google, Amazon, Apple, or Nvidia - it's a small, under-the-radar stock trading for just a few dollars.
This company holds 98 registered patents in voice and sound recognition technology and has secured partnerships with Honda, Netflix, Pandora, and Mercedes-Benz. Get the full details on this under-the-radar AI stock now
But investors still seem wary. Growth may not be the issue facing the company. Compared with other countries, the United States is still far behind in pet insurance adoption. Instead, veterinary inflation and industry competition may be the reasons investors remain underwhelmed and why patience could be required. Trupanion Delivers Stronger Financial ResultsTrupanion is not typically mentioned in conversations about insurers. It does not pay a dividend, and subscription insurance for cats and dogs is a niche that rarely attracts much investor attention. The company is also unusual in the insurance world because its policies are monthly rather than annual contracts that customers renegotiate each year. The company’s first quarter results showed, however, that its model is working. For the first three months of the year, Trupanion reported revenue rose 12% to $384 million compared with a year earlier, topping expectations. The company’s net income swung from a $1.5 million loss a year ago to a profit of $4.9 million, or 11 cents per share, more than 50% above analyst estimates. Adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) rose 42% to $17.4 million. While the earnings beat was notable, operating margins told an even more compelling story. Trupanion’s subscription adjusted operating margin rose to 14.2%, a first-quarter record, up from 12.9%. Adjusted operating income also rose 29% year-over-year to more than $40 million. Subscriber Loyalty Remains a StrengthTrupanion’s business extends beyond its direct cat-and-dog insurance operations in the United States. The company also operates lower-cost Furkin and PHI Direct brands in Canada, employer programs, and pet health products. Its VetDirect Pay service allows its insurance coverage to integrate with veterinary claims systems. Over the past few years, the company has also expanded through acquisitions into several European countries, though that remains a small part of the business with only about 64,000 pets covered. For a company built on monthly subscriptions, that line item is critical, and it tells a generally positive story. Overall, subscription revenue for the quarter rose 16% to $269.5 million on a 5% increase in enrolled subscription pets to 1.1 million. Factoring in all business lines, total pets enrolled declined 2% year-over-year. Still, monthly average revenue per pet increased to $85.79, compared with $77.53 a year earlier. This growth is being sustained largely by apparent loyalty among subscribers. As of March 31, Trupanion reported monthly retention of 98.35%, meaning fewer than two out of every 100 subscribers canceled. In all, the company announced in May that it had reached more than $4 billion in total veterinary invoices paid on behalf of policyholders. Competition and Rising Costs Still MatterGiven the nature of the business, investors cannot simply assume a smooth trajectory from here. With its monthly subscription model, the company still faces the risk of churn and pricing pressure. Competition is also intensifying in the financial services sector. Traditional insurers, direct-to-consumer startups, and employer-benefit pet insurance programs have all entered or expanded in the category. Nationwide, Lemonade (NYSE: LMND), MetLife (NYSE: MET), and the Healthy Paws unit of Chubb (NYSE: CB) are among the other players in the segment. On the positive side, Trupanion’s distribution model relies heavily on recommendations from veterinarians, which provides some protection. Even so, maintaining that advantage requires continued investment in veterinary relationships and brand presence. The cost to acquire new subscribers is also increasing, rising to $315 in the quarter from $267. Meanwhile, veterinary costs have climbed sharply over the past decade, driven by advances in veterinary medicine that now include MRI imaging, cancer treatments, orthopedic surgeries, and other procedures that can cost thousands of dollars. Wall Street Remains Cautiously OptimisticAnalyst opinion, as well as the company’s stock price, reflects these tensions. Despite the improved results, shares in the company have fallen by over 35% since the start of the year. Over the past year, the stock is down more than 50%. And while two analysts have assigned a Buy rating to the stock, three analysts recommend Hold, and one suggests Sell, indicating just how tentative the outlook remains. Overall, the company carries a Hold rating. Even with the Hold rating, the company’s lowest 12-month target price is $31, still well above current trading levels. The average target is $42.25, more than 75% higher. Growth Potential May Reward PatienceFor investors considering Trupanion, patience may be the key. Pet insurance remains dramatically underpenetrated in North America, so there is plenty of room to grow. In the United Kingdom and Sweden, for example, pet insurance ownership rates are well into the double digits. In the United States and Canada, the figure remains in the low single digits. The first-quarter results also deserve attention. A record operating margin and a strong earnings beat should not be ignored, along with continued proof that the subscription model generates the kind of customer loyalty that supports long-term economics. For retail investors who are comfortable owning a company that is still proving its profitability story, TRUP deserves a place on the research list. That said, this is not a stock for investors who need certainty or income. The company is still in the process of proving its profitability. The next one or two quarterly reports are likely to be clarifying. The first quarter of 2026 was certainly encouraging. But in Trupanion’s case, the full story continues to be written. |
